Unusual Presentation of a Uterine Leiomyosarcoma with Predominant Metastasis to the Liver: A Case Report with Gross and Histological Validation
Authors/Creators
- 1. South Dakota State University
- 2. Des Moines University
- 3. University of Nebraska Medical Center
Description
Uterine Leiomyosarcoma (uLMS) are malignant mesenchymal tumors known to metastasize preferentially to the lungs. The present study concerns a female human body donor of postmenopausal age with known diagnosis of uLMS. Upon dissection and gross examination, an enlarged uterus and tumor-ridden liver were observed, however the lungs appeared typical except for a single palpable nodule on the superior lobe of the left lung. Immunohistochemical analysis of the liver tumors confirmed their myogenic origin and thus suggested uLMS distant metastasis, but the analyses of the lung nodule showed typical tissue architecture with no presence of myosin or actin. Illustrating gross and histological analyses of this unusual case with the relevant clinical information may assist biomedical research scientists, inform medical educators, and help physicians better understand uLMS with this metastatic pattern.
Notes
Files
unusual-presentation-of-a-uterine-leiomyosarcoma-with-predominant-metastasis-to-the-liver-a-case-report-with-gross-and-h.pdf
Additional details
References
- Singh Z. Leiomyosarcoma: A rare soft tissue cancer arising from multiple organs.J Cancer Res Pract. 2018; 5(1):1-8.
- Skorstad M, Kent A, Lieng M. Uterine Leiomyosarcoma – incidence, treatment, and the impact of morcellation. A nationwide cohort study.Acta Obstet Gynecol Scand. 2016; 95(9):984-990.
- Sun S, Bonaffini PA, Nougaret S, Fournier Let al.How to differentiate uterine Leiomyosarcoma from leiomyoma with imaging.Diagn interv imaging. 2019; 100(10):619-634.
- Wang L, Li S, Zhang Z, Jia J et al. Prevalence and occult rates of uterine Leiomyosarcoma.Medicine (United States). 2020; 99(33).
- Tirumani SH, Deaver P, Shinagare AB, Tirumani Het al.Metastatic pattern of uterine leiomyosarcoma: Retrospective analysis of the predictors and outcome in 113 patients.J Gynecol Oncol. 2014; 25(4):306–312.
- D'Angelo E, Prat J. Uterine sarcomas: A review.Gynecologic Oncology. 2010; 116(1):131–139.
- El-Khalfaoui K, Bois A, Heitz F, Kurzeder C et al. Current and future options in the management and treatment of uterine sarcoma.TherAdvMedOncol. 2014; 6(1):21–28.
- Rose PG, Steven Piver M, Tsukada Y, Lau T. Patterns of metastasis in uterine sarcoma. An autopsy study.Cancer. 1989; 63(5):935–938, 1989.
- Momtahan M, Emami F, Aslani FS, Akbarzadeh-Jahromi M. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.J Chin Med Assoc. 2020; 83(1):84–88.
- Juhasz-Böss I, Gabriel L, Bohle RM, Horn LC et al. Uterine Leiomyosarcoma.Oncol Res Treat. 2018; 41(11):680–686.
- Zhang G, Yu X, Zhu L, Fan Q et al. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.BMC Cancer. 2020; 20(1).
- Huang YT, Huang YL, Ng KK, Lin G. Current status of magnetic resonance imaging in patients with malignant uterine neoplasms: A review.KJR. 2019; 20(1):18–33.
- Hughes L, Roex A, Parange A. STUMP, a surprise finding in a large fibroid uterus in a 20-year-old woman.Int J Womens Health. 2018; 10:211–214.
- Cui RR, Wright JD, Hou JY. Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.BJOG: Int. J Obstet Gynaecol. 2017; 124(7):1028–1037.
- Santos P, Cunha TM. Uterine sarcomas: Clinical presentation and MRI features.Diagnostic and Interventional Radiology. 2015; 21(1):4–9.
- Cree IA, Tan PH, Travis WD, Wesseling Pet al.Counting mitoses: SI (ze) matters!Modern Pathology. 2021; 34:1651–1657.
- Mayerhofer K, Obermair A, Windbichler G, Petru Eet al.Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases.Gynecol Oncol. 1999; 74(2):196–201.
- Arend RC, Toboni MD, Montgomery AM, Burger RAet al.Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.Oncologist. 2018; 23(12):1533–1545.
- Damerell V, Pepper MS, Prince S. Molecular mechanisms underpinning sarcomas and implications for current and future therapy.Signal Transduction and Targeted Therapy. 2021; 6(1).
- George S, Serrano C, Hensley ML, Ray-Coquard I. Soft tissue and uterine Leiomyosarcoma.Journal of Clinical Oncology. 2018; 36(2):144–150.